The Influence of Hip Replacement on Lower Extremity Hemodynamics in Crowe IV Hip Dysplasia Patient
1 other identifier
interventional
100
0 countries
N/A
Brief Summary
Explore the influence of hip replacement on lower extremity hemodynamics in Crowe Ⅳ hip dysplasia patient.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started Nov 2019
Longer than P75 for not_applicable
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
October 23, 2019
CompletedStudy Start
First participant enrolled
November 1, 2019
CompletedFirst Posted
Study publicly available on registry
November 8, 2019
CompletedPrimary Completion
Last participant's last visit for primary outcome
November 1, 2021
CompletedStudy Completion
Last participant's last visit for all outcomes
November 1, 2023
CompletedNovember 8, 2019
October 1, 2019
2 years
October 23, 2019
November 6, 2019
Conditions
Outcome Measures
Primary Outcomes (6)
Hip Harris Score
change of hip harris score scale from baseline(preoperative) to 1 year after surgery.
preoperative, 1 week, 6 weeks, 12 weeks, 24 weeks and 1 year after the surgery.
Leg Length Change
change of Leg Length from baseline(preoperative) to 1 year after surgery.
preoperative, 1 week, 6 weeks, 12 weeks, 24 weeks and 1 year after the surgery.
Radiographic Results
change of Radiographic Results from 1 week after surger to 1 year after surgery
1 week, 12 weeks, 24 weeks and 1 year after the surgery.
Lower Limb Arterial CT Angiography
change of vascular diameter and vascular cross-sectional from baseline(preoperative) to 1 year after surgery baseline(preoperative) to 12 weeks after surgery.
preoperative, 1 week, 12 weeks after the surgery.
Vascular Ultrasound Examination
change of systolic peak velocity, end-diastolic velocity, pulsation index, resistance index and blood flow from baseline(preoperative) to 1 year after surgery.
preoperative, 1 week, 6 weeks, 12 weeks, 24 weeks and 1 year after the surgery.
Blood Viscosity
change of blood viscosity from baseline(preoperative) to 1 year after surgery.
preoperative, 1 week, 6 weeks, 12 weeks, 24 weeks and 1 year after the surgery.
Study Arms (2)
total hip replacement with subtrochanteral osteotomy
EXPERIMENTALsubtrochanteral osteotomy is applied during total hip replacement
total hip replacement with no osteotomy
SHAM COMPARATORno osteotomy is applied during total hip replacement.
Interventions
applying subtrochanteral osteotomy during the operation to release the tension of vessels and nerve
just total hip replacement
Eligibility Criteria
You may qualify if:
- Unilateral Crow IV hip dysplasia;
- Bilateral Crow IV hip dysplasia without osteoarthritis on the other side
You may not qualify if:
- Patients with serious medical disease;
- Patients with lower extremity vascular disease; 3. Patients with severe mental illness.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- STUDY CHAIR
SHIGUI YAN, MD
2nd affiliated hospital, School of Medicine, Zhejiang University
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- TRIPLE
- Who Masked
- PARTICIPANT, INVESTIGATOR, OUTCOMES ASSESSOR
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
October 23, 2019
First Posted
November 8, 2019
Study Start
November 1, 2019
Primary Completion
November 1, 2021
Study Completion
November 1, 2023
Last Updated
November 8, 2019
Record last verified: 2019-10